⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL36385 | 0.75 | — | — | |
| SCHEMBL15054859 | 0.75 | HDAC8 (0.35) | — | |
| SCHEMBL6767656 | 0.74 | — | — | |
| SCHEMBL31107108 | 0.73 | — | — | |
| SCHEMBL2731913 | 0.71 | — | — | |
| SCHEMBL1389123 | 0.69 | — | — | |
| SCHEMBL8810777 | 0.69 | — | — | |
| SCHEMBL130185 | 0.69 | — | — | |
| SCHEMBL15870907 | 0.67 | MEN1 (0.45) | — | |
| SCHEMBL6158176 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115490668-B | Pyrimidylimidazole compound, preparation method thereof and organic solderability preservative | 深圳市贝加电子材料有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-115490668-A | Pyrimidyl imidazole compound, preparation method thereof and organic weldable protective agent | 深圳市贝加电子材料有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-102858743-A | Spiro-condensed cyclohexane derivatives as HSL inhibitors useful for the treatment of diabetes | HOFFMANN LA ROCHE | 2013-01-02 | — | — | CN | claimed |
| CN-102421777-A | Azacyclospiro derivatives as HSL inhibitors | HOFFMANN LA ROCHE | 2012-04-18 | — | — | CN | claimed |
| CN-100549011-C | Novel imidazopyridine as cell cycle protein dependent kinase inhibitor | SCHERING CORP (US) | 2009-10-14 | — | — | CN | claimed |
| US-7071199-B1 | Kinase inhibitors as therapeutic agents | ABBOTT GMBH & CCO. KG (DE) | 2006-07-04 | — | — | US | claimed |
| CN-1703414-A | Novel imidazopyridines as cyclin dependent kinase inhibitors | SCHERING CORP (US) | 2005-11-30 | — | — | CN | claimed |
| CN-1227548-A | Substituted p-trifluoromethylphenyluracils | BAYER AG (DE) | 1999-09-01 | — | — | CN | claimed |
| CN-1216538-A | Substituted 2-aryl-1,2,4-triazine-3,5-di(thi) ones as herbicides | BAYER AG (DE) | 1999-05-12 | — | — | CN | claimed |
| CN-1192208-A | Phenylpyridazinones | BAYER AG (DE) | 1998-09-02 | — | — | CN | claimed |
| EP-0544819-B1 | INDOLE DERIVATIVES WHICH INHIBIT LEUKOTRIENE BIOSYNTHESIS | ABBOTT LAB (US) | 1995-12-06 | — | — | EP | claimed |
| EP-0544819-A4 | INDOLE DERIVATIVES WHICH INHIBIT LEUKOTRIENE BIOSYNTHESIS | — | 1993-10-20 | — | — | EP | claimed |
| EP-0544819-A1 | INDOLE DERIVATIVES WHICH INHIBIT LEUKOTRIENE BIOSYNTHESIS. | ABBOTT LAB (US) | 1993-06-09 | — | — | EP | claimed |
| WO-1992003132-A1 | INDOLE DERIVATIVES WHICH INHIBIT LEUKOTRIENE BIOSYNTHESIS | ABBOTT LABORATORIES (US) | 1992-03-05 | — | — | WO | claimed |
| EP-0349921-A2 | Etheral n-terminal aminodiol amino acid derivatives as anti-hypertensive agents | G.D. Searle & Co. (US) | 1990-01-10 | — | — | EP | claimed |
| CN-115490668-B | Pyrimidylimidazole compound, preparation method thereof and organic solderability preservative | 深圳市贝加电子材料有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-115490668-A | Pyrimidyl imidazole compound, preparation method thereof and organic weldable protective agent | 深圳市贝加电子材料有限公司 | 2022-12-20 | — | — | CN | disclosed |
| WO-1992003132-A1 | INDOLE DERIVATIVES WHICH INHIBIT LEUKOTRIENE BIOSYNTHESIS | ABBOTT LABORATORIES (US) | 1992-03-05 | — | — | WO | disclosed |
| WO-1990000051-A1 | ETHEREAL N-TERMINAL AMINODIOL AMINO ACID DERIVATIVES AS ANTI-HYPERTENSIVE AGENTS | G.D. SEARLE & CO. (US) | 1990-01-11 | — | — | WO | disclosed |
| EP-0349921-A2 | Etheral n-terminal aminodiol amino acid derivatives as anti-hypertensive agents | G.D. Searle & Co. (US) | 1990-01-10 | — | — | EP | disclosed |